Structure |
Chemical Name |
CAS |
MF |
|
Bosentan hydrate |
157212-55-0 |
C27H31N5O7S |
|
Bosentan |
147536-97-8 |
C27H29N5O6S |
|
Ambrisentan |
177036-94-1 |
C22H22N2O4 |
|
Rimonabant |
168273-06-1 |
C22H21Cl3N4O |
|
Tolvaptan |
150683-30-0 |
C26H25ClN2O3 |
|
Cinacalcet hydrochloride |
364782-34-3 |
C22H23ClF3N |
|
Ramelteon |
196597-26-9 |
C16H21NO2 |
|
8-[(E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-7-methyl-purine-2,6 -dione |
155270-99-8 |
C20H24N4O4 |
|
Plerixafor 8HCl (AMD3100 8HCl) |
155148-31-5 |
C28H54N8 |
|
PLERIXAFOR |
110078-46-1 |
C28H54N8 |
|
Suvorexant |
1030377-33-3 |
C23H23ClN6O2 |
|
SB408124 |
288150-92-5 |
C19H18F2N4O |
|
BML-190 |
2854-32-2 |
C23H23ClN2O4 |
|
N1,N4-Di-2-pyridinyl-1,4-benzenedimethanamine |
55778-02-4 |
C18H18N4 |
|
Sitaxentan sodium |
210421-74-2 |
C18H14ClN2NaO6S2 |
|
NPS 2143 |
284035-33-2 |
C24H25ClN2O2 |
|
Mozavaptan |
137975-06-5 |
C27H29N3O2 |
|
AM 251 |
183232-66-8 |
C22H21Cl2IN4O |
|
CGS 21680A |
124431-80-7 |
C23H30ClN7O6 |
|
N-(2-METHYL-6-BENZOOXAZOLYL)-N''-1,5-NAPHTHYRIDIN-4-YL UREA |
792173-99-0 |
C17H13N5O2 |
|
SB 225002 |
182498-32-4 |
C13H10BrN3O4 |
|
SKI II |
312636-16-1 |
C15H11ClN2OS |
|
CP 945598 hydrochloride |
686347-12-6 |
C25H26Cl3N7O |
|
Zibotentan (ZD4054) |
186497-07-4 |
C19H16N6O4S |
|
GW 842166X |
666260-75-9 |
C18H17Cl2F3N4O2 |
|
(R)-2-((R)-6,7-diMethoxy-1-(4-(trifluoroMethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-Methyl-2-phenylacetaMide |
913358-93-7 |
C29H31F3N2O3 |
|
5-chloro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-piperidin-1-yl-phenyl)-ethyl]-amide |
868273-06-7 |
C24H28ClN3O |
|
MK 3207 hydrochloride |
957116-20-0 |
C31H30ClF2N5O3 |
|
(R,S)-AM1241 |
444912-48-5 |
C22H22IN3O3 |
|
BAF-312(SiponiMod) |
1230487-00-9 |
C29H35F3N2O3 |
|
Ki16198 |
355025-13-7 |
C24H25ClN2O5S |
|
PF 543 |
1415562-82-1 |
C27H31NO4S |
|
KI16425 |
355025-24-0 |
C23H23ClN2O5S |